IL6 and ovarian carcinoma: IL-6-STAT3 signaling axis has been shown to be relevant to pathogenesis of ovarian cancer, with phosphorylation/activation and subsequent nuclear translocation of STAT3 being frequent events in ovarian cancers, resulting in poor prognosis [17].